Author: UT Health Science Center | Category: Around Campus | August 17, 2015
Dr. Veronica Galvan, a Ph.D., researcher at the Barshop Institute will be speaking at Texas Public Radio’s inaugural Think Health Science event, “A Leap Toward a Treatment for Alzheimer’s Disease,” on Sept. 9 at 7 p.m. in Pestana Lecture Hall.
She will focus on the latest research and discoveries related to the treatment of Alzheimer’s disease. The event is free and open to the public.
Dr. Galvan studies the biology of Alzheimer’s disease at the UT Health Science Center Barshop Institute, one of the world’s most renowned aging research institutes. Dr. Galvan’s lab team has discovered that rapamycin, a drug that delays aging, reverses Alzheimer’s-like memory deficits and has other desirable effects in the brains of mice that model the disease.
This is the first time that the progression of Alzheimer’s-like disease, or any other dementia modeled in mice, has been blocked by a drug that slows aging.
The "Think Health Science" series is designed to shed light on the latest medical advancements, as distinguished researchers and scientists share discoveries and fascinating research that’s happening here in San Antonio.
The lectures and panels that will be a part of the series will cover a broad variety of topics and research areas, from newly discovered treatments and breakthroughs to innovative research that carry the potential to radically change lives.
RSVP for the event here.
Copyright © 2017 The University of Texas Health Science Center at San Antonio
Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.